Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Aug. 22, 2022	Feb. 17, 2022
Business Acquisition [Line Items]
Goodwill	$ 27,946	$ 26,713
La Jolla Pharmaceutical Company
Business Acquisition [Line Items]
Cash and cash equivalents			$ 47,415
Short-term marketable securities			471
Accounts receivable			5,876
Inventory			66,200
Prepaid expenses			1,261
Other current assets			907
Property and equipment, net			13
Right-of-use assets			226
Goodwill			16,453
Intangible assets	151,000		151,000
Other assets			710
Total assets acquired			290,532
Accounts payable			1,237
Deferred revenue, current			2,849
Other accrued liabilities			11,362
Other long-term liabilities			65,944
Deferred tax liabilities			2,581
Total liabilities assumed			83,973
Total assets acquired, net			$ 206,559
Entasis Therapeutics Holdings Inc
Business Acquisition [Line Items]
Cash and cash equivalents				$ 23,070
Prepaid expenses				5,554
Other current assets				1,959
Property and equipment, net				185
Right-of-use assets				959
Goodwill				11,493
Intangible assets	$ 106,700			106,700
Other assets				302
Total assets acquired				150,222
Accounts payable				1,583
Accrued personnel-related expenses				1,058
Other current liabilities				5,096
Deferred tax liabilities				7,769
Total liabilities assumed				15,506
Total assets acquired, net				$ 134,716